What does PHARMACIE FRANCOISE CASSIVELAN do?

PHARMACIE FRANCOISE CASSIVELAN is a pharmacy in Fontaine-l'Evêque. Private Limited, started on 12 February 1993, 1 establishment.

What is the address of PHARMACIE FRANCOISE CASSIVELAN?

The registered office of PHARMACIE FRANCOISE CASSIVELAN is located at Grand-Rue(F-E) 39, 6140 Fontaine-l'Evêque.

Is PHARMACIE FRANCOISE CASSIVELAN still active?

Yes. According to the CBE (17 September 2026) PHARMACIE FRANCOISE CASSIVELAN is active, legal situation “Normale toestand”, started on 12 February 1993.

Is PHARMACIE FRANCOISE CASSIVELAN registered on Peppol?

Yes, PHARMACIE FRANCOISE CASSIVELAN is registered on the Peppol network with ID 0208:0449339434.

What is the enterprise number of PHARMACIE FRANCOISE CASSIVELAN?

The enterprise number of PHARMACIE FRANCOISE CASSIVELAN is BE0449339434.

When was PHARMACIE FRANCOISE CASSIVELAN founded?

PHARMACIE FRANCOISE CASSIVELAN was founded on 12 February 1993.

Who are the directors of PHARMACIE FRANCOISE CASSIVELAN?

According to the 2024 annual accounts, the directors of PHARMACIE FRANCOISE CASSIVELAN are: FRANCOISE CASSILAN.

Is PHARMACIE FRANCOISE CASSIVELAN a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 12 February 1993; 4 annual accounts filed, latest fiscal year 2024; 1 directors known from the annual account.

How much profit did PHARMACIE FRANCOISE CASSIVELAN make in 2024?

PHARMACIE FRANCOISE CASSIVELAN posted a profit after taxes of € 64,384 in financial year 2024.

What is the revenue of PHARMACIE FRANCOISE CASSIVELAN?

As a small company, PHARMACIE FRANCOISE CASSIVELAN is not required to publish revenue in its annual accounts. In financial year 2024, its added value was € 202,519.

How much does an employee at PHARMACIE FRANCOISE CASSIVELAN earn?

The average wage cost per full-time employee at PHARMACIE FRANCOISE CASSIVELAN was € 41,600 in 2021: staff costs of € 83,127 for 2 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

PHARMACIE FRANCOISE CASSIVELAN (Private Limited)

Dossier PHARMACIE FRANCOISE CASSIVELAN, printed on 17 September 2026 from databakkes.be/en/0449339434/pharmacie-francoise-cassivelan. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2024

PHARMACIE FRANCOISE CASSIVELAN from Fontaine-l'Evêque, company number BE0449339434, closed financial year 2024 with a result of € 64,384 after tax. For that financial year PHARMACIE FRANCOISE CASSIVELAN recorded a gross margin of € 202,519 and equity of € 571,213. Compared with financial year 2023, the result moved from € 51,917 to € 64,384. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2025.

What it is worth Growing

€ 571,213

▲ 13% vs 2023

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 64,384

▲ 24% vs 2023

Profit after tax over the fiscal year.

Cash in the bank

€ 458,615

▲ 8% vs 2023

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2024. Retained profit grew to € 552,621.

People and assets in 2024

Wage cost

€ 96,007

▲ 2% vs 2023

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 1,238

▼ 68% vs 2023

Book value of vehicles, furniture and equipment.

Debts at end 2024

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 44,924

▲ 12% vs 2023

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 35,824

▲ 7% vs 2023

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2021	2022	2023	2024	Change 2023 → 2024
Gross margin	€ 162,818 Gross margin 2021: € 162,818 First fiscal year in the series	€ 155,273 Gross margin 2022: € 155,273 ▼ 5% vs 2021 (€ 162,818) Unfavourable step	€ 198,592 Gross margin 2023: € 198,592 ▲ 28% vs 2022 (€ 155,273) Favourable step	€ 202,519 Gross margin 2024: € 202,519 ▲ 2% vs 2023 (€ 198,592) Favourable step	▲ 2%
Profit after taxes	€ 31,806 Profit after taxes 2021: € 31,806 First fiscal year in the series	€ 30,889 Profit after taxes 2022: € 30,889 ▼ 3% vs 2021 (€ 31,806) Unfavourable step	€ 51,917 Profit after taxes 2023: € 51,917 ▲ 68% vs 2022 (€ 30,889) Favourable step	€ 64,384 Profit after taxes 2024: € 64,384 ▲ 24% vs 2023 (€ 51,917) Favourable step	▲ 24%
Equity	€ 424,023 Equity 2021: € 424,023 First fiscal year in the series	€ 454,912 Equity 2022: € 454,912 ▲ 7% vs 2021 (€ 424,023) Favourable step	€ 506,829 Equity 2023: € 506,829 ▲ 11% vs 2022 (€ 454,912) Favourable step	€ 571,213 Equity 2024: € 571,213 ▲ 13% vs 2023 (€ 506,829) Favourable step	▲ 13%
Total debts	€ 43,563 Total debts 2021: € 43,563 First fiscal year in the series	€ 84,067 Total debts 2022: € 84,067 ▲ 93% vs 2021 (€ 43,563) Unfavourable step	€ 73,762 Total debts 2023: € 73,762 ▼ 12% vs 2022 (€ 84,067) Favourable step	€ 80,748 Total debts 2024: € 80,748 ▲ 9% vs 2023 (€ 73,762) Unfavourable step	▲ 9%
Cash	€ 326,029 Cash 2021: € 326,029 First fiscal year in the series	€ 382,709 Cash 2022: € 382,709 ▲ 17% vs 2021 (€ 326,029) Favourable step	€ 426,034 Cash 2023: € 426,034 ▲ 11% vs 2022 (€ 382,709) Favourable step	€ 458,615 Cash 2024: € 458,615 ▲ 8% vs 2023 (€ 426,034) Favourable step	▲ 8%
Retained profit	€ 405,431 Retained profit 2021: € 405,431 First fiscal year in the series	€ 436,320 Retained profit 2022: € 436,320 ▲ 8% vs 2021 (€ 405,431) Favourable step	€ 488,237 Retained profit 2023: € 488,237 ▲ 12% vs 2022 (€ 436,320) Favourable step	€ 552,621 Retained profit 2024: € 552,621 ▲ 13% vs 2023 (€ 488,237) Favourable step	▲ 13%
Balance sheet total	€ 467,586 Balance sheet total 2021: € 467,586 First fiscal year in the series	€ 538,979 Balance sheet total 2022: € 538,979 ▲ 15% vs 2021 (€ 467,586) Unchanged	€ 580,591 Balance sheet total 2023: € 580,591 ▲ 8% vs 2022 (€ 538,979) Unchanged	€ 651,961 Balance sheet total 2024: € 651,961 ▲ 12% vs 2023 (€ 580,591) Unchanged	▲ 12%
Employees (FTE)	2 Employees (FTE) 2021: 2 First fiscal year in the series	-	-	-

Key figures of PHARMACIE FRANCOISE CASSIVELAN, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.

What happened to PHARMACIE FRANCOISE CASSIVELAN?

What happened at PHARMACIE FRANCOISE CASSIVELAN in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 31, 2025 New annual accounts for financial year 2024: profit of € 64,384 (▲ 24% vs 2023). filed late Source: NBB ↗
Apr 19, 1993 New establishment in Fontaine-l'Evêque. KBO
Feb 12, 1993 Start of the company according to the CBE. KBO

In short

From € 31,806 profit in 2021 to € 64,384 profit in 2024.

Paid € 85,806 in corporate taxes since 2021.

Best year ever: 2024, with € 64,384 profit.

On average € 81,400 of value added per employee in 2021.

Original PDFs at the National Bank ↗

A new publication or filing at PHARMACIE FRANCOISE CASSIVELAN? We notify you, reason included.

Follow PHARMACIE FRANCOISE CASSIVELAN

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

FRANCOISE CASSILAN

PHARMACIE FRANCOISE CASSIVELAN

Behind PHARMACIE FRANCOISE CASSIVELAN is FRANCOISE CASSILAN.

See the full network in the app

Directors

According to the 2024 annual accounts

FRANCOISE CASSILAN

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Grand-Rue(F-E) 39

6140 Fontaine-l'Evêque

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

Association des copropriétaires Grand Rue, 39 à Fontaine l'Evêque

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0449.339.434

VAT number

BE 0449.339.434

Registered office

Grand-Rue(F-E) 39, 6140 Fontaine-l'Evêque

Names & denominations

PHARMACIE FRANCOISE CASSIVELAN

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

12 February 1993

Peppol

Active · Active since 2 Dec 2025

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

PHARMACIE FRANCOISE CASSIVELAN

Financials

What happened to PHARMACIE FRANCOISE CASSIVELAN?

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Management

Directors

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions